Oncimmune Holdings, a London-listed immunodiagnostics developer, has announced significant leadership changes. Martin Gouldstone will…
Tag:
Oncimmune Holdings, a London-listed immunodiagnostics developer, has announced significant leadership changes. Martin Gouldstone will…